INTRAVENOUS INSULIN VARIABILITY PREDICTS GLYCAEMIC VARIABILITY IN INSULIN-TREATED ACUTE RESPIRATORY PATIENTS WITH DIABETES, BUT NOT THOSE WITH NORMAL GLUCOSE TOLERANCE

被引：0
|
作者：
Misra, S. [1 ]
Archer, J. R. H. [2 ]
Simmgen, M. [3 ]
Reddy, M. [1 ]
Jones, P. [4 ]
Baker, E. [4 ]
Oliver, N. S. [1 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, London, England
[2] St Thomas Hosp, London, England
[3] Roscommon Country Hosp, Roscommon, Ireland
[4] St Georges Univ London, Div Biomed Sci, London, England
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2014年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A139 / A140
页数：2
相关论文
共 50 条
  • [1] ASSESSMENT OF GLYCAEMIC VARIABILITY (GV) IN INSULIN-TREATED ACUTE RESPIRATORY PATIENTS WITH AND WITHOUT DIABETES
    Misra, S.
    Archer, J. R.
    Simmgen, M.
    Jones, P. W.
    Oliver, N. S.
    Baker, E. H.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 : A131 - A132
  • [2] Lixisenatide reduces glycaemic variability in insulin-treated patients with type 2 diabetes
    Umpierrez, Guillermo E.
    O'Neal, David
    DiGenio, Andres
    Goldenberg, Ronald
    Hernandez-Triana, Eric
    Lin, Jay
    Park, Cheol-Young
    Renard, Eric
    Kovatchev, Boris
    [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (09): : 1317 - 1321
  • [3] Impact of acute-phase insulin secretion on glycemic variability in insulin-treated patients with type 2 diabetes
    Si, Yiming
    Shen, Yun
    Lu, Jingyi
    Ma, Xiaojing
    Zhang, Lei
    Mo, Yifei
    Lu, Wei
    Zhu, Wei
    Bao, Yuqian
    Hu, Gang
    Zhou, Jian
    [J]. ENDOCRINE, 2020, 68 (01) : 116 - 123
  • [4] IMPACT OF ACUTE-PHASE INSULIN SECRETION ON GLYCEMIC VARIABILITY IN INSULIN-TREATED PATIENTS WITH TYPE 2 DIABETES
    Zhou, J.
    Si, Y.
    Shen, Y.
    Lu, J.
    Ma, X.
    Zhang, L.
    Mo, Y.
    Lu, W.
    Zhu, W.
    Bao, Y.
    Jia, W.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A147 - A147
  • [5] Impact of acute-phase insulin secretion on glycemic variability in insulin-treated patients with type 2 diabetes
    Yiming Si
    Yun Shen
    Jingyi Lu
    Xiaojing Ma
    Lei Zhang
    Yifei Mo
    Wei Lu
    Wei Zhu
    Yuqian Bao
    Gang Hu
    Jian Zhou
    [J]. Endocrine, 2020, 68 : 116 - 123
  • [6] Low c-peptide is associated with high glycaemic variability and hypoglycaemia in insulin-treated patients with Type 2 diabetes
    Hope, S. V.
    Knight, B. A.
    Shields, B. M.
    Strain, W. D.
    Hattersley, A. T.
    Choudhary, P.
    Jones, A. G.
    [J]. DIABETIC MEDICINE, 2016, 33 : 18 - 18
  • [7] Glycaemic variability and hypoglycaemia are associated with C-peptide levels in insulin-treated type 2 diabetes
    Christensen, M. B.
    Gaede, P.
    Hommel, E.
    Gotfredsen, A.
    Norgaard, K.
    [J]. DIABETES & METABOLISM, 2020, 46 (01) : 61 - 65
  • [8] Sources of glucose variability in insulin-treated type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES)
    Murata, GH
    Duckworth, WC
    Shah, JH
    Wendel, CS
    Hoffman, RM
    [J]. CLINICAL ENDOCRINOLOGY, 2004, 60 (04) : 451 - 456
  • [9] Glycemic Variability as Predictor of Clinical Outcome in Insulin-Treated Patients With Type 2 Diabetes
    Farrokhi, Farnoosh
    Smiley, Dawn
    Pasquel, Francisco
    Peng, Limin
    Newton, Christopher
    Olson, Darin E.
    Jacobs, Sol
    Umpierrez, Guillermo E.
    [J]. DIABETES, 2013, 62 : A245 - A245
  • [10] A study of glycaemic variability and cost analysis of intravenous insulin therapies (intravenous insulin therapy vs glucose, kallum, insulin infusion regimen)
    Durkan, A.
    Khan, M. A.
    Ahmad, A.
    Sharma, D.
    Purewal, T.
    Weston, P.
    Zaidi, R.
    [J]. DIABETIC MEDICINE, 2016, 33 : 152 - 153
12345